🇺🇸 FDA
Patent

US 11510929

Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids

granted A61KA61K31/439A61K31/5513

Quick answer

US patent 11510929 (Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids) held by The Regents of the University of California expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/439, A61K31/5513, A61K31/5517, A61K31/57